Bruker Announces Date and Time of First Quarter 2019 Earnings Release and Webcast

BILLERICA, Mass., April 23, 2019 /PRNewswire/ -- Bruker (NASDAQ: BRKR) today announced it will report first quarter 2019 financial results on Thursday May 2, 2019, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends.


Bruker and the Translational Metabolic Laboratory at Radboud University Medical Center Announce the Establishment of a Joint Center of Excellence for Translational Omics

At the opening event of the Netherlands X-omics Initiative, Bruker and the Translation Metabolic Laboratory (TML) at Radboud University Medical Center (UMC) today jointly announce the establishment of a Center of Excellence (CoE) for Translational Omics.


Bruker Announces Further Portfolio Expansion for Microbial Identification, Infection Control and Molecular Diagnostics of Infectious Diseases

AMSTERDAM, The Netherlands – April 15, 2019 – At the European Congress of Clinical Microbiology and Infectious Diseases (, Bruker announces new assays, software and library extensions for its MALDI Biotyper, IR Biotyper and Fluorocycler XT product lines for microbial identification, infection control and molecular diagnostics of infectious diseases.

2019年4月 9日

DKSH and Bruker AXS strengthen partnership in China

DKSH is expanding its partnership with Bruker AXS to China. DKSH will drive sales for Bruker’s energy dispersive X-ray fluorescence benchtop spectrometers for elemental analysis.

2019年4月 8日

Bruker Announces World's First Superconducting 1.1 Gigahertz Magnet for High-Resolution NMR in Structural Biology

Homogeneous 25.9 Tesla Standard-bore NMR Magnet Sets New World Record